Developmental Core

发展核心

• 批准号: 7847112
• 负责人: Jaydutt V. Vadgama
• 金额: $ 177.69万
• 依托单位: CHARLES R. DREW UNIVERSITY OF MED & SCI
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7847112
• 关键词: Acute Lymphocytic Leukemia; Adhesions; African American; Age; Ambulatory Care; Arts; Binding; Biological; Biological Process; Birds; Brain; Breast; Breast Cancer Cell; Cancer Death Rates; Cancer Etiology; Cancer Patient; Cancer Research Project; Cancer cell line; Caucasians; Caucasoid Race; Cell physiology; Central American; Cessation of life; Characteristics; Chemopreventive Agent; Chickens; Clinical; Complex; Cysteine; Data; Development; Diagnosis; Disease; Dominant-Negative Mutation; Endometrial Carcinoma; Esophageal Squamous Cell Carcinoma; Ethnic group; Extracellular Matrix; Family; Family member; Fibroblasts; Focal Adhesion Kinase 1; Future; Gene Family; Genes; Genomics; Glioma; Goals; Growth; Growth Factor; Hispanic Americans; Hispanics; Homologous Gene; Human; Immunohistochemistry; In Vitro; Incidence; Insulin-Like Growth-Factor-Binding Proteins; Integrins; Kidney; Knowledge; Laboratories; Latina; Lead; Lung; Malignant Neoplasms; Malignant neoplasm of esophagus; Malignant neoplasm of prostate; Mammary Gland Parenchyma; Mammary Neoplasms; Measures; Medical center; Messenger RNA; Mexican; Minority; Mus; Names; National Cancer Institute; Nephroblastoma; Not Hispanic or Latino; Outcome; Ovary; PI3K/AKT; Paraffin; Partner in relationship; Pathogenesis; Pathway interactions; Patients; Peptide Signal Sequences; Play; Population; Prognostic Marker; Property; Protein Binding; Protein Family; Proteins; RNA; Rattus; Research Personnel; Resistance; Role; Running; Sampling; Satellite Viruses; Science; Services; Signal Transduction; Staging; Staining method; Stains; Survival Rate; Techniques; Testing; The Sun; Therapeutic; Tissue Microarray; Transgenic Animals; Transgenic Mice; Transgenic Organisms; Underserved Population; Universities; Validation; WISP1 gene; Woman; Work; angiogenesis; bone; cancer diagnosis; cancer therapy; chemotherapy; human FRAP1 protein; in vivo; insight; integrin-linked kinase; malignant breast neoplasm; melanoma; member; mortality; novel; novel therapeutics; osteosarcoma; outcome forecast; overexpression; protein expression; receptor; research study; response; therapeutic target; tumor; tumor progression; tumorigenesis; tumorigenic; von Willebrand Factor